跳至主要内容
临床试验/EUCTR2018-000565-36-FI
EUCTR2018-000565-36-FI进行中(未招募)1 期

Paracetamol and ibuprofen/indomethacin in closing persistent ductus arteriosus - The PAI study

niversity of Oulu0 个研究点目标入组 60 人开始时间: 2018年4月25日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • - premature infants
  • - treated in the neonatal intensive care units of the attending sites
  • - diagnosed to have a hemodynamically significant patent ductus arteriosus
  • - intravenous ibuprofen or indomethacin medication
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - no parental consent
  • - any congenital or chromosomal anomaly or severe clinical situation that complicates the conventional ductal therapy, e.g. severe asphyxia or persistent pulmonary hypertension of a newborn

研究者

发起方
niversity of Oulu

相似试验